Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
PMCUF
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Top 3 Australian Quality Stocks To Watch In October 2026
IMF warnings about record public debt are pushing investors toward businesses that can fund themselves without relying heavily on lenders. That puts Australian companies with robust profitability and conservative balance sheets in the spot…
Top 3 Australian Founder Run Stocks To Watch In October 2026
Energy prices are back in the spotlight as the IMF warns that persistent shocks from oil and gas threaten global growth, and that puts management quality under a harsh spotlight. Australian founder-led companies often have leaders whose we…
Is Pro Medicus (ASX:PME) Quietly Recasting Its Technology Ambitions With Tim Reed’s Board Appointment?
Pro Medicus Limited has appointed experienced technology leader Tim Reed as an independent Non-Executive Director, effective October 1, 2026, adding deep software, governance and investment expertise to its board. Reed's track record in sc…
3 Australian Quality Stocks To Watch In September 2026
With Australia's cash rate now at a 15-year high, money in the bank finally pays something again, but inflation and higher borrowing costs still eat into real wealth. That is why investors are paying closer attention to companies with soli…
3 Australian Founder Led Stocks With Revenue Growth Up To 37%
With Australian interest rates now at a 15-year high, cheap debt no longer does the heavy lifting for corporate performance. Investors are paying closer attention to who is actually steering each business. Founder led Australian companies,…
Top 3 Australian Quality Stocks To Watch In September 2026
New rules on financial transparency in global supply chains are putting weak balance sheets under the microscope. Businesses that cannot clearly show lenders and customers they are financially sound may find contracts harder to win and fun…
Pro Medicus Ltd (PMCUF) (FY 2026) Earnings Call Highlights: Record Revenue and Strategic ...
This article first appeared on GuruFocus. Revenue: $261.7 million for FY26, up from the prior year. Underlying EBIT: $196 million, with margins just under 75%, up 90 basis points. Constant Currency Growth: EBIT and NPAT grew over 30% on a…
Visage Highlights One Platform AI-Optimized at SIIM26
Visage releases native Visage 7 | Reporting SAN DIEGO, June 8, 2026 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will demonstrate the unmatched value of One Pla…
Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. But as Peter Lynch s…
Visage Elevates AI Optimized Enterprise Imaging at HIMSS26
Visage releases Visage 7.1.20, including Visage 7 Web and Visage Chat+ SAN DIEGO, March 10, 2026 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will highlight a s…
Pro Medicus Signs 5-Year Renewal With MedStar Including Visage 7 Cardiology Module
(RTTNews) - Pro Medicus Limited (PME.AX) announced that its wholly owned U.S. subsidiary, Visage Imaging Inc., has signed a five-year contract renewal with MedStar Health, a major health system serving the Maryland and Washington, D.C. met…
Pro Medicus' (ASX:PME) Attractive Earnings Are Not All Good News For Shareholders
Investors were disappointed with Pro Medicus Limited's (ASX:PME) recent earnings release. Our analysis found several concerning factors in the earnings report beyond the strong statutory profit number. This technology could replace compute…
Capital Investment Trends At Pro Medicus (ASX:PME) Look Strong
What are the early trends we should look for to identify a stock that could multiply in value over the long term? Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of…
Pro Medicus Ltd (PMCUF) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Growth
This article first appeared on GuruFocus. Revenue: Increased by 28.4%. Underlying EBIT: Up approximately 30%. EBIT Margins: Increased period on period. Cash and Investments: Increased by 5.3% despite buybacks, increased dividends, and a $1…
High Growth Tech Stocks In Australia For February 2026
As Australian shares continue their upward momentum, marking a third consecutive advance in Week 7, investors are keenly focused on February's earnings season, which is poised to influence market dynamics significantly. In this environment…
The Australian stock market is experiencing a potential rebound, with shares expected to rise by over 1% following recent sell-offs, as investors anticipate the Reserve Bank of Australia's impending interest rate hike decision. In this dyn…
As Australian shares continue their upward trajectory, buoyed by a rally in the S&P 500 and anticipation surrounding upcoming inflation data, investors are closely watching how these factors might influence future Reserve Bank of Australia…
Pro Medicus (ASX:PME) sheds 3.5% this week, as yearly returns fall more in line with earnings growth
Pro Medicus Limited (ASX:PME) shareholders might be concerned after seeing the share price drop 29% in the last quarter. But over five years returns have been remarkably great. To be precise, the stock price is 401% higher than it was five…
Exploring Three High Growth Tech Stocks In Australia
The Australian market has recently shown resilience, with the ASX200 experiencing a positive run, buoyed by higher gold and silver prices and an uptick in materials stocks. In this environment, identifying high growth tech stocks involves…
Artrya And 2 Other High Growth Tech Stocks With Potential In Australia
As the Australian market kicks off 2026, the ASX has been relatively flat with a brief pause in the Santa Rally, while IT stocks have led declines amidst broader market uncertainties. In this environment, identifying high-growth tech stock…
With 49% ownership, insiders at Pro Medicus Limited (ASX:PME) are pretty optimistic and have been buying recently
Key Insights Pro Medicus' significant insider ownership suggests inherent interests in company's expansion 52% of the business is held by the top 4 shareholders Insiders have been buying lately Trump has pledged to "unleash" American oil a…
Exploring High Growth Tech Stocks in Australia Featuring Three Prominent Companies
As the Australian market edges towards the holiday season, it is experiencing a slight dip, largely attributed to profit-taking as major global indices approach record highs. In this context, high growth tech stocks in Australia can offer…
As the Australian market navigates a mixed landscape with tech stocks showing resilience amidst broader sector fluctuations, investors are keenly observing how economic indicators and global events influence small-cap performance. In this…
As the Australian market experiences a tentative rise, with shares initially pointing towards gains before potential afternoon reversals, investors are closely monitoring economic indicators and broader market sentiment that could impact s…
Pro Medicus Insiders Placed Bullish Bets Worth AU$15.0m
Over the last year, a good number of insiders have significantly increased their holdings in Pro Medicus Limited (ASX:PME). This is encouraging because it indicates that insiders are more optimistic about the company's prospects. Although…
The Australian market recently experienced technical issues with the ASX announcements outage, affecting several companies and contributing to a slight downturn in the S&P/ASX 200 index. In this environment, investors may be keen to identi…
High Growth Tech Stocks In Australia For November 2025
As the Australian market navigates a period of mixed sentiment, with the S&P/ASX 200 (XJO) rebounding to 8,600 points despite inflation climbing to 3.8%, investors are closely watching sectors like IT which recently lagged behind materials…
Visage Propels AI Optimized Enterprise Imaging at RSNA 2025
Visage introduces Visage 7 | Digital Pathology and AI innovations SAN DIEGO, Nov. 19, 2025 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will showcase a series o…
Exploring High Growth Tech Stocks in Australia This November 2025
As Australian shares brace for a challenging day with the ASX 200 futures indicating a significant drop, the market sentiment has been further unsettled by both domestic political shifts and international economic disruptions. In this clim…
High Growth Tech Stocks in Australia for November 2025
The Australian market has been navigating a period of uncertainty, with key indices fluctuating due to geopolitical events and rising inflation, while sectors like materials have shown resilience amidst these challenges. In this environmen…
Here's Why Pro Medicus (ASX:PME) Has Caught The Eye Of Investors
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Sometimes these stories can cloud the minds of investors, leading them to invest wi…
Wisetech Global And 2 Other Promising Australian Tech Stocks With Growth Potential
Amidst a backdrop where Australian shares are charting their own course with a modest gain, diverging from the cautious sentiment seen on Wall Street, the tech sector continues to capture attention as it benefits from positive earnings and…
The Australian market recently experienced a dip, with the ASX down 0.3% as investors awaited key CPI data and closely monitored geopolitical developments, such as the US-China diplomatic talks. In this environment of cautious optimism and…
Exploring High Growth Tech Stocks In Australia October 2025
As of October 2025, the Australian market has shown resilience with the S&P/ASX 200 index climbing past the 9,000-point mark despite mixed economic signals such as weak jobs data and stronger-than-expected inflation. In this dynamic enviro…
As the Australian market remains relatively stable with the ASX ending slightly in the red midweek, investors are keeping a keen eye on sectors showing resilience and potential for growth, particularly within the tech space. In this enviro…
Pro Medicus Limited (ASX:PME) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
With its stock down 5.2% over the past three months, it is easy to disregard Pro Medicus (ASX:PME). But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in…